• Mashup Score: 0
    AI-enhanced breath analysis has ‘good performance’ in detecting COVID-19 - 7 month(s) ago

    Use of real-time mass spectrometry breath analysis that has been enhanced by artificial intelligence is a potential COVID-19 screening method, according to a presentation at the European Respiratory Society International Congress.“We found that this method had good performance to detect COVID-19 with high-throughput, because … the test’s length is less than 1 minute,”

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      Presented at the #ERSCongress: Use of real-time mass spectrometry breath 😮💨 analysis that has been enhanced by artificial intelligence 🧠 is a potential #COVID19 #screening method. @EuroRespSoc https://t.co/w6bIEH1E0g

  • Mashup Score: 0
    Annual Henry Ford Cancer Institute Multi-Disciplinary Breast Oncology Symposium - Henry Ford Health - Continuing Education (CE) - 8 month(s) ago

    Henry Ford Health, Annual Henry Ford Cancer Institute Multi-Disciplinary Breast Oncology Symposium, 9/22/2023 8:00:00 AM – 9/22/2023 4:15:00 PM, Exciting progress is underway regarding surgical options for the breast and axilla in neoadjuvant chemotherapy patients, lymphedema prevention. The evolution of the role of genomic profiling and genetic testing. Physicians involved with the diagnosis and management of breast cancer patients need to be kept apprised of new information in all of these areas.

    Source: hfhs.cloud-cme.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HenryFordNews
      HenryFordNews

      Reminder! Join us virtually or in person on Sept. 22 for our #BreastCancer symposium - bringing together top thought leaders to discuss current #screening recommendations, evolving genomic medicine, radiation treatment options and more. Register now: https://t.co/kycB6w9rsm https://t.co/TCNlxxHt9h

  • Mashup Score: 0
    Breast Cancer Screening and 10-Year Net Survival in Canadian Women Aged 40 to 49 - The ASCO Post - 8 month(s) ago

    In a Canadian study reported in the Journal of Clinical Oncology, Wilkinson et al found that breast cancer screening was associated with greater 10-year breast cancer net survival among women aged 40 to 49 living in jurisdictions including mammography screening programs for this age group, compared with women aged 50 to 59 in jurisdictions that do not include screening in this age group. The incidence of breast cancer diagnosis in the 40- to 49-year age group did not differ in the two types of jurisdiction

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Breast Cancer Screening and 10-Year Net Survival in Canadian Women Aged 40 to 49 https://t.co/L2kIBApFPZ #bcsm #breastcancer #screening

  • Mashup Score: 1
    Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years - 9 month(s) ago

    PURPOSE In Canada, some provincial/territorial mammography screening programs include women age 40-49 years, whereas others do not. This study examines the impact of this dichotomy on the 10-year breast cancer (BC) net survival (NS) among women age 40-49 years and 50-59 years at diagnosis. METHODS Using the Canadian Cancer Registry data record linked to death information, we evaluated the cohort of Canadian women age 40-49 years and 50-59 years diagnosed with BC from 2002 to 2007. We compared 10-year NS estimates in the jurisdictions with organized screening programs that included women age 40-49 years, designated as screeners (Northwest Territories, British Columbia, Alberta, Nova Scotia, and Prince Edward Island), with comparator programs that did not (Yukon, Manitoba, Saskatchewan, Ontario, Quebec, New Brunswick, and Newfoundland and Labrador). RESULTS BC was the primary cause of 10-year mortality in women age 40-49 years diagnosed with BC (90.7% of deaths). Among these women, the 1

    Source: ascopubs.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO_pubs
      ASCO_pubs

      👀 Check out what’s popular this week in #JCO: Impact of #BreastCancer #Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years ➡️ https://t.co/AXaoEZIutF #CancerPrevention #BCSM @Anwilkinson https://t.co/ye0ssaEfWk

  • Mashup Score: 0
    Annual Henry Ford Cancer Institute Multi-Disciplinary Breast Oncology Symposium - Henry Ford Health - Continuing Education (CE) - 9 month(s) ago

    Henry Ford Health, Annual Henry Ford Cancer Institute Multi-Disciplinary Breast Oncology Symposium, 9/22/2023 8:00:00 AM – 9/22/2023 4:15:00 PM, Exciting progress is underway regarding surgical options for the breast and axilla in neoadjuvant chemotherapy patients, lymphedema prevention. The evolution of the role of genomic profiling and genetic testing. Physicians involved with the diagnosis and management of breast cancer patients need to be kept apprised of new information in all of these areas.

    Source: hfhs.cloud-cme.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HenryFordNews
      HenryFordNews

      Join us on Sept. 22 for our annual #BreastCancer symposium as we bring together top thought leaders to discuss current breast #screening recommendations, the evolving role of genomic medicine, radiation treatment options and more. Register now: https://t.co/kycB6w9rsm https://t.co/5U2gZyRiJv

  • Mashup Score: 0
    AI-Supported Screen Reading vs Standard Double Reading in Mammography Screening for Breast Cancer - The ASCO Post - 9 month(s) ago

    In a Swedish study (Mammography Screening with Artificial Intelligence [MASAI]) reported in The Lancet Oncology, Lång et al found that artificial intelligence (AI)-supported screen reading was associated with a similar cancer detection rate and a lower screen-reading workload vs standard double reading for patients undergoing mammography screening for breast cancer. The current report is a prespecified clinical safety analysis, performed after 80,000 patients were enrolled in the study. In the MASAI

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      AI-Supported Screen Reading vs Standard Double Reading in Mammography Screening for Breast Cancer https://t.co/A0kUvwpuXy #bcsm #breastcancer #oncology #AI #screening

  • Mashup Score: 0
    EBV-Based Screening Methods for Identifying Nasopharyngeal Carcinoma - The ASCO Post - 9 month(s) ago

    In a Taiwanese study reported in the Journal of Clinical Oncology, Lou et al compared two methods of Epstein-Barr Virus (EBV)-screening to identify nasopharyngeal carcinoma. Blood samples were obtained from 819 incident Taiwanese nasopharyngeal carcinoma cases (including 213 cases of early-stage disease) diagnosed between 2010 to 2014, as well as from 1,768 controls matched for age and sex from the same region. EBV assessments consisted of an EBV antibody score using immunoglobulin A antibodies measured

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      EBV-Based Screening Methods for Identifying Nasopharyngeal Carcinoma https://t.co/oHdEhUXuQz #EBV #screening #hncsm #headneckcancer #oncology

Load More